Compounded Tirzepatide Results: 12-Month Outcome Report
Introduction
Compounded tirzepatide is the same dual GIP/GLP-1 agonist molecule as Mounjaro® and Zepbound®, made by licensed 503A or 503B pharmacies and dispensed through telehealth platforms like TrimRx. When titrated to the same target dose, the 12-month outcomes track closely with the SURMOUNT-1 trial.
SURMOUNT-1 (Jastreboff et al. 2022, NEJM) is the reference dataset. Participants on tirzepatide 15 mg weekly lost an average of 20.9% of body weight at week 72. The 10 mg dose produced 19.5%, and the 5 mg dose produced 15.0%. The 12-month figures land at roughly 18-19% on 15 mg, 17-18% on 10 mg, and 13-14% on 5 mg.
Here’s a realistic look at what compounded tirzepatide produces at the 12-month mark, what drives the variability, and how to push your outcome toward the top of the range.
At TrimRx, we believe that understanding your options is the first step toward a more manageable health journey. You can take the free assessment quiz if you’re ready to see whether a personalized program is a fit for you.
What’s the Average 12-month Weight Loss on Compounded Tirzepatide?
The 12-month average on compounded tirzepatide at therapeutic doses is 17-19% of starting body weight. For 220 pounds, that’s 37-42 pounds. For 280 pounds, 48-53 pounds. For 200 pounds, 34-38 pounds.
Quick Answer: 12-month average loss on compounded tirzepatide is 17-19% on the 10-15 mg dose
SURMOUNT-1 ran 72 weeks (about 16 months), and most of the weight loss happened in the first 40-50 weeks. By month 12, participants were already at 90-95% of their final outcome.
About 36% of SURMOUNT-1 participants on 15 mg hit 25% body weight loss by week 72. About 57% hit 20% loss. These are real numbers from a 2,539-participant trial published in NEJM, and they match what TrimRx clinicians see in compounded tirzepatide patients.
What Happens in Month 1 on Compounded Tirzepatide?
Month 1 on compounded tirzepatide typically produces 3-5% body weight loss. SURMOUNT-1 averaged 2.7% at week 4 on the 2.5 mg starter dose.
The 2.5 mg dose is intentionally low. It’s a tolerability dose. Real fat loss accelerates at 5 mg and beyond. Most of month 1’s scale movement is water and gut content as gastric emptying slows.
Side effects in month 1 are usually mild. About 18-22% of SURMOUNT-1 participants reported nausea. Constipation is more common than diarrhea. Most side effects fade within 1-2 weeks of starting a new dose.
How Much Loss Is Normal by Month 3?
By the end of month 3 on tirzepatide, most patients have hit 7-9% body weight loss. SURMOUNT-1 hit 7% at week 12.
For 230 pounds starting, that’s 16-21 pounds in three months. For 270 pounds, about 19-24 pounds.
Month 3 is usually when food noise drops to near zero. Many TrimRx patients describe it as the easiest month of the entire 12-month timeline. Cravings for sweets and processed carbs fade significantly at the 7.5 mg dose.
What Does Month 6 Typically Look Like on Tirzepatide?
Month 6 produces an average of 13-16% body weight loss on compounded tirzepatide. SURMOUNT-1 showed 15.0% on 10 mg and 16.1% on 15 mg by week 24.
For 250 pounds starting, that’s 33-40 pounds in six months. For 220 pounds, about 29-35 pounds.
By month 6, most patients have reached their maintenance dose (10 mg or 15 mg) and have been there for at least 4-8 weeks. Appetite suppression is steady. Resistance training matters most here for preserving lean mass during the rapid loss phase.
What Changes Between Months 6 and 12?
The rate of weight loss slows in the second half of the year. Months 1-6 typically produce 13-16% loss, while months 7-12 add another 4-6%. That’s why 12-month totals land at 17-19% on therapeutic doses.
Your body finds a new set point. Lower mass means lower BMR, lower NEAT, and adapted appetite signaling. SURMOUNT-1 showed weight loss continuing slowly out to week 72, but the rate dropped from about 0.7% per week in months 3-5 down to under 0.3% per week by month 11-12.
Some patients hit a plateau at month 8-10 and stay there. Others continue slow steady loss through month 18-24.
What’s the Difference Between 10 Mg and 15 Mg Outcomes?
The gap between 10 mg and 15 mg is smaller than most people expect. SURMOUNT-1 showed 19.5% on 10 mg vs 20.9% on 15 mg at week 72. That’s a 1.4 percentage point difference for a 50% higher dose.
For most patients, 10 mg is the sweet spot for total loss vs side effects. If you’re tolerating 10 mg well and losing at your goal rate, there’s no requirement to push higher. The 12.5 mg and 15 mg doses are useful for plateau breaks or patients with higher starting weights.
TrimRx clinicians adjust dose based on response, not just protocol. Some patients land at 7.5 mg long-term with strong results.
Key Takeaway: Month 3 averages 7-8% based on SURMOUNT-1 data
What Slows Compounded Tirzepatide Results?
Common factors that slow results include inadequate protein (under 0.6 g per pound of body weight), heavy alcohol use, skipping doses, sleeping under 7 hours per night, and untreated thyroid or PCOS issues.
Liquid calories quietly cancel deficits. Tirzepatide slows solid food intake more than liquid intake. Smoothies, sweetened lattes, and diet sodas paired with frequent eating can blunt results meaningfully.
The IDEA trial (Messier 2013, JAMA) showed exercise roughly doubles fat loss vs caloric restriction alone. Resistance training 2-3 times per week and walking 8-10k steps daily are the highest-use additions to any GLP-1 protocol.
How Does Compounded Tirzepatide Compare to Compounded Semaglutide?
Tirzepatide produces about 5-7 percentage points more loss than semaglutide at 12 months. SURMOUNT-5 (2025) showed roughly 20% loss on tirzepatide vs 13.7% on semaglutide over 72 weeks.
The gap shows up in month 3-4 and widens through month 12. Tirzepatide also tends to produce stronger appetite suppression, which makes adherence easier for many patients.
Tirzepatide isn’t right for everyone. Some patients tolerate semaglutide better. Cost is usually similar between compounded versions. TrimRx offers both and can switch you between them based on response. The free assessment quiz matches you with the right starting medication.
What Does Muscle Loss Look Like at 12 Months?
DEXA substudies from SURMOUNT-1 and SURPASS trials show roughly 25-35% of weight lost on tirzepatide is lean mass when no resistance training is done. That’s similar to semaglutide and to weight loss from caloric restriction alone.
Adding 2-3 resistance training sessions per week shifts the ratio to roughly 80/20 fat-to-lean. Protein at 0.7-1.0 g per pound of goal body weight further protects lean mass.
For a 60-pound loss at 12 months without training, expect 15-20 pounds of lean mass loss. With training and protein, that drops to 10-12 pounds.
What Happens If You Stop Compounded Tirzepatide at 12 Months?
The SURMOUNT-4 trial (Aronne et al. 2024, JAMA) tested this. Participants who switched from tirzepatide 15 mg to placebo after 36 weeks regained about 14% of body weight over the next 52 weeks, while those who continued tirzepatide lost an additional 5.5%.
Most patients regain a substantial portion of lost weight within 12-18 months of stopping. Maintenance dosing (sometimes lower than therapeutic dose) is how the drug works long-term.
TrimRx offers maintenance protocols that step down to lower doses once goal weight is reached, balancing cost, side effects, and weight stability.
Bottom line: Tirzepatide outperforms semaglutide by 5-7 percentage points at 12 months
FAQ
Is Compounded Tirzepatide as Effective as Brand Mounjaro?
When dosed identically with the same titration, yes. Same molecule, same mechanism. Quality varies by compounder, so use a provider that sources from licensed 503A or 503B pharmacies.
What’s the Average Month 12 Loss on Tirzepatide?
About 17-19% on the 10-15 mg dose, based on SURMOUNT-1 data and matched TrimRx outcomes. For 240 pounds, that’s 41-46 pounds.
Can I Lose 100 Pounds on Tirzepatide in a Year?
Possible only if your starting weight is 350+ pounds. The trial average at 12 months is 17-19% of starting weight, so 100 pounds in a year requires a 525+ pound starting weight to be average.
Why Am I Plateaued at Month 8 on Tirzepatide?
Common reasons include reaching a natural set point, low protein, no resistance training, untreated thyroid issues, or liquid calorie habits. Dose increases sometimes help if you’re not at 15 mg yet.
How Long Should I Stay on Tirzepatide?
Long-term, based on current evidence. SURMOUNT-4 showed substantial regain after stopping. Most clinicians treat obesity as chronic and use long-term maintenance dosing.
Can I Switch From Semaglutide to Tirzepatide for Better Results?
Yes, and it often helps slow semaglutide responders. About 30-40% of patients who plateau on semaglutide see meaningful additional loss after switching to tirzepatide.
What’s the Cheapest Way to Get 12 Months of Tirzepatide?
Compounded tirzepatide through telehealth typically runs $300-500 per month vs $1,000+ for brand. TrimRx offers multi-month supply pricing that reduces monthly cost further.
Disclaimer: This content is for informational purposes only and does not constitute medical advice. It is not intended to diagnose, treat, cure, or prevent any disease or condition. Individual results may vary. Always consult a qualified healthcare professional before starting any weight loss program or medication.
Related Articles
Transforming Lives, One Step at a Time
Keep reading
Tirzepatide for Men: How Results Differ From Women
The clinical trials for tirzepatide included both men and women, and the headline results, average weight loss of around 20 percent of body weight…
Tirzepatide for Women Over 50: Menopause, Metabolism, and What to Expect
Women over 50 who start tirzepatide are working with a set of biological variables that don’t exist in younger patients, and understanding those variables…
Regaining Weight After Stopping Tirzepatide: What to Expect
Weight regain after stopping tirzepatide is one of the most searched and least clearly answered questions in the GLP-1 space. Patients want to know…
